Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

SARS-CoV-2 spike proteins directly activate the APC, which can be blocked by factor D inhibition

Nov. 9, 2020

Positive interim phase III data released for lenzilumab in hospitalized patients with COVID-19

Nov. 9, 2020

CAN-COVID trial of canakinumab in patients with COVID-19 pneumonia and CRS misses endpoints

Nov. 6, 2020

Phase II extension study of vebicorvir in HBV does not achieve meaningful SVR rates

Nov. 6, 2020

Phase I data presented for iCo-019, novel oral formulation of amphotericin B

Nov. 6, 2020

Preclinical data on EBS-LASV vaccine presented

Nov. 6, 2020

Acurx reports phase IIa data on ibezapolstat in C. difficile infection

Nov. 6, 2020

PK and safety data for nacubactam in combination with beta-lactams

Nov. 5, 2020

Hoth outlines progress within COVID-19 pipeline

Nov. 5, 2020

Aligos begins first-in-human trial of ALG-000184 for chronic hepatitis B

Nov. 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.